Justice Department Sues Provider of Chicken and Pork Data

[ad_1] What to Read Next [ad_2] Source link

Amgen Could Get a Piece of the Obesity Market

[ad_1] Amgen has a couple of shots on goal to break into one of the biggest markets the pharmaceutical industry has ever seen. [ad_2] Source link

The Big Pharma Stock Trade: Weight Loss Is In, Covid-19 Is Out

[ad_1] What to Read Next [ad_2] Source link

To Pay for Weight Loss Drugs, Some Take Second Jobs, Ring Up Credit-Card Debts

[ad_1] Some people are paying more than $10,000 a year for Ozempic and Mounjaro. [ad_2] Source link

The Ozempic Craze Could Put These Companies on a Crash Diet

[ad_1] Anti-obesity medications could affect industries that benefit from America’s food problem. [ad_2] Source link

Get In on This Skin Disease Drug Before Big Pharma Does

[ad_1] What to Read Next [ad_2] Source link

The Score: Eli Lilly, WeWork, Walt Disney and More Stocks That Defined the Week

[ad_1] Here are some of the major companies whose stocks moved on the week’s news. [ad_2] Source link

The obesity drugs waiting to hit the market

[ad_1] Novo Nordisk said a large study had shown its highly effective obesity drug Wegovy also had a clear cardiovascular benefit, boosting the Danish drugmaker’s hopes of moving beyond Wegovy’s…

Stocks Resume Slide After Bank Downgrades

[ad_1] What to Read Next [ad_2] Source link

The Obesity Drug Revolution Just Got Real

[ad_1] New data show Novo Nordisk’s Wegovy reduces risk of heart attack and stroke, paving the way for greater insurance coverage. [ad_2] Source link